WHO ICTRP trial
The effects of midazolam and flumazenil on cerebral circulation
JPRN-UMIN000012777 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000012777 |
|---|---|
| Public title | The effects of midazolam and flumazenil on cerebral circulation |
| Scientific title | The effects of midazolam and flumazenil on cerebral circulation - Midazolam, flumazenil and cerebral circulation |
| Primary sponsor | Division of Hygiene, Department of Social Medicine, Nihon University School of Medicine |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | healthy subjects |
| Interventions | Healthy male subjects receives midazolam followed by flumazenil. Midazolam is administered at an initial bolus dose of 0.5 mg, and an additional bolus dose of 0.5 mg is administered every 2 min after OAA/S assessment until an OAA/S score of… |
| Registration date | Jul 1, 2014 |
| Target size | 20 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: